Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9795806, 11 pages
https://doi.org/10.1155/2017/9795806
Research Article

Integrative Approach to Facilitate Fracture Healing: Topical Chinese Herbal Paste with Oral Strontium Ranelate

1Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
2State Key Laboratory of Phytochemistry and Plant Resources in West China, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
3Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Correspondence should be addressed to Ping-Chung Leung; kh.ude.khuc@gnuelcgnip

Received 2 August 2017; Accepted 6 December 2017; Published 31 December 2017

Academic Editor: Yuri Clement

Copyright © 2017 Wing-Sum Siu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Court-Brown and B. Caesar, “Epidemiology of adult fractures: a review,” Injury, vol. 37, no. 8, pp. 691–697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Morrison, J. Magaziner, M. A. McLaughlin et al., “The impact of post-operative pain on outcomes following hip fracture,” PAIN, vol. 103, no. 3, pp. 303–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. MacKenzie, M. J. Bosse, J. F. Kellam et al., “Characterization of patients with high-energy lower extremity trauma,” Journal of Orthopaedic Trauma, vol. 14, no. 7, pp. 455–464, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Lippuner, J. von Overbeck, R. Perrelet, H. Bosshard, and P. Jaeger, “Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland,” Osteoporosis International, vol. 7, no. 5, pp. 414–425, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Kilgore, M. A. Morrisey, D. J. Becker et al., “Health care expenditures associated with skeletal fractures among medicare beneficiaries, 1999–2005,” Journal of Bone and Mineral Research, vol. 24, no. 12, pp. 2050–2055, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. National Osteoporosis Society, 25th anniversary report – A fragile future, 2011.
  7. K. Shakouri, B. Eftekharsadat, M. R. Oskuie et al., “Effect of low-intensity pulsed ultrasound on fracture callus mineral density and flexural strength in rabbit tibial fresh fracture,” Journal of Orthopaedic Science, vol. 15, no. 2, pp. 240–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. M. Calori, E. Mazza, M. Colombo, and C. Ripamonti, “The use of bone-graft substitutes in large bone defects: any specific needs?” Injury, vol. 42, supplement 2, pp. S56–S63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Wernike, M.-O. Montjovent, Y. Liu et al., “VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo,” European Cells and Materials, vol. 19, pp. 30–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Mokbel, N. Naaman, J. Nohra, and N. Badawi, “Healing patterns of critical size bony defects in rats after grafting with bone substitutes soaked in recombinant human bone morphogenetic protein-2: histological and histometric evaluation,” British Journal of Oral and Maxillofacial Surgery, vol. 51, no. 6, pp. 545–549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Aspenberg, “Drugs and fracture repair,” Acta Orthopaedica, vol. 76, no. 6, pp. 741–748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. V. Bukata, “Systemic administration of pharmacological agents and bone repair: What can we expect,” Injury, vol. 42, no. 6, pp. 605–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. R. Jorgensen and P. Schwarz, “Effects of anti-osteoporosis medications on fracture healing,” Current Osteoporosis Reports, vol. 9, no. 3, pp. 149–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-P. Lecart and J.-Y. Reginster, “Current options for the management of postmenopausal osteoporosis,” Expert Opinion on Pharmacotherapy, vol. 12, no. 16, pp. 2533–2552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. L. Ong, M. L. Villarraga, E. Lau, L. Y. Carreon, S. M. Kurtz, and S. D. Glassman, “Off-label use of bone morphogenetic proteins in the United States using administrative data,” The Spine Journal, vol. 35, no. 19, pp. 1794–1800, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. M. Alkhiary, L. C. Gerstenfeld, E. Krall et al., “Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34),” The Journal of bone and joint surgery. American volume, vol. 87, no. 4, pp. 731–741, 2005. View at Google Scholar
  17. P. Peichl, L. A. Holzer, R. Maier, and G. Holzer, “Parathyroid hormone 1–84 accelerates fracture-healing in pubic bones of elderly osteoporotic women,” The Journal of Bone and Joint Surgery—American Volume, vol. 93, no. 17, pp. 1583–1587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Aspenberg, H. K. Genant, T. Johansson et al., “Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures,” Journal of Bone and Mineral Research, vol. 25, no. 2, pp. 404–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Maïmoun, T. C. Brennan, I. Badoud, V. Dubois-Ferriere, R. Rizzoli, and P. Ammann, “Strontium ranelate improves implant osseointegration,” Bone, vol. 46, no. 5, pp. 1436–1441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. F. Li, E. Luo, G. Feng, S. S. Zhu, J. H. Li, and J. Hu, “Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats,” Osteoporosis International, vol. 21, no. 11, pp. 1889–1897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Jolette, C. E. Wilker, S. Y. Smith et al., “Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats,” Toxicologic Pathology, vol. 34, no. 7, pp. 929–940, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Watanabe, S. Yoneyama, M. Nakajima et al., “Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34)),” Journal of Toxicological Sciences, vol. 37, no. 3, pp. 617–629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Tastekin and C. Zateri, “Probable osteosarcoma risk after prolonged teriparatide treatment: Comment on the article by Saag et al,” Arthritis & Rheumatology, vol. 62, no. 6, p. 1837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Bonnelye, A. Chabadel, F. Saltel, and P. Jurdic, “Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro,” Bone, vol. 42, no. 1, pp. 129–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Habermann, K. Kafchitsas, G. Olender, P. Augat, and A. Kurth, “Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing,” Calcified Tissue International, vol. 86, no. 1, pp. 82–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. H. Peng, C. H. Ko, S. W. Siu et al., “In vitro and in vivo assessment of a herbal formula used topically for bone fracture treatment,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 282–289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. W.-S. Siu, C.-H. Ko, K.-W. Lam et al., “Evaluation of a topical herbal agent for the promotion of bone healing,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 905270, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Tse, H. Cheng, C. Tso et al., “Does Topical Agent Help Fracture Healing? A Pilot Study Using a Herbal Patch,” Open Journal of Therapy and Rehabilitation, vol. 03, no. 02, pp. 35–39, 2015. View at Publisher · View at Google Scholar
  29. G. M. Blake, J. E. Compston, and I. Fogelman, “Could strontium ranelate have a synergistic role in the treatment of osteoporosis?” Journal of Bone and Mineral Research, vol. 24, no. 8, pp. 1354–1357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Chinese Pharmacopoeia Commisison, Pharmacopoeia of the People’s Republic of China, Chinese Medical Science and Technology Press, Beijing, China, 2015.
  31. C. H. Ko, W. S. Siu, C. P. Lau, C. B. S. Lau, K. P. Fung, and P. C. Leung, “Osteoprotective effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats,” Chinese Medicine, vol. 5, article 39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-S. Siu, H.-L. Wong, C.-P. Lau et al., “The effects of an antiosteoporosis herbal formula containing epimedii herba, ligustri lucidi fructus and psoraleae fructus on density and structure of rat long bones under tail-suspension, and its mechanisms of action,” Phytotherapy Research, vol. 27, no. 4, pp. 484–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. B. Habal, “Controlled bone regeneration: the ultimate process in bone repair,” Clinics in Plastic Surgery, vol. 29, no. 1, pp. 15–27, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Cebesoy, E. Tutar, K. C. Kose, Y. Baltaci, and C. Bagci, “Effect of strontium ranelate on fracture healing in rat tibia,” Joint Bone Spine, vol. 74, no. 6, pp. 590–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. R. M. Ibrahim, S. Singh, A. M. Merican et al., “The effect of strontium ranelate on the healing of a fractured ulna with bone gap in rabbit,” BMC Veterinary Research, vol. 12, no. 1, article no. 112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. K. E. Ozturan, B. Demir, I. Yucel, H. Cakici, F. Yilmaz, and A. Haberal, “Effect of strontium ranelate on fracture healing in the osteoporotic rats,” Journal of Orthopaedic Research, vol. 29, no. 1, pp. 138–142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Schenk, “Biology of Fracture Repair,” in Skeletal Trauma: Basic Science, Management, and Reconstruction, B. D. Browner, J. P. Jupiter, A. M. Levine, and P. G. Trafton, Eds., pp. 29–73, Saunders, 2003. View at Google Scholar
  38. X. Guo, S. Wei, M. Lu et al., “Dose-dependent effects of strontium ranelate on ovariectomy rat bone marrow mesenchymal stem cells and human umbilical vein endothelial cells,” International Journal of Biological Sciences, vol. 12, no. 12, pp. 1511–1522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Barbara, P. Delannoy, B. G. Denis, and P. J. Marie, “Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells,” Metabolism, vol. 53, no. 4, pp. 532–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Canalis, M. Hott, P. Deloffre, Y. Tsouderos, and P. J. Marie, “The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro,” Bone, vol. 18, no. 6, pp. 517–523, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. M. M. Almeida, E. P. Nani, L. N. Teixeira et al., “Strontium ranelate increases osteoblast activity,” Tissue & Cell, vol. 48, no. 3, pp. 183–188, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Peng, X. S. Liu, T. Wang et al., “In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells,” Journal of Orthopaedic Research, vol. 28, no. 9, pp. 1208–1214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Baron and Y. Tsouderos, “In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation,” European Journal of Pharmacology, vol. 450, no. 1, pp. 11–17, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Caudrillier, A.-S. Hurtel-Lemaire, A. Wattel et al., “Strontium ranelate decreases receptor activator of nuclear factor-κB ligand-induced osteoclastic differentiation in vitro: Involvement of the calcium-sensing receptor,” Molecular Pharmacology, vol. 78, no. 4, pp. 569–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Takahashi, T. Sasaki, Y. Tsouderos, and T. Suda, “S 12911-2 inhibits osteoclastic bone resorption in vitro,” Journal of Bone and Mineral Research, vol. 18, no. 6, pp. 1082–1087, 2003. View at Publisher · View at Google Scholar · View at Scopus